This is the authors' abstract. We don't add key points for this paper.
from phenylalanine of cisplatin-sensitive cells, while in cisplatin-resistant cells, proteins were the most affected cell components. These results provided spectral features specific to malignancy that led to discrimination between drug-treated and untreated cells. This knowledge is essential for the rational design of improved drugs with a higher efficiency coupled to lower toxicity.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: